Formulation of a Novel Hesperetin-Loaded Nanoemulsion and Its Promising Effect on Osteogenesis
Pharmaceutics · 23.05.2024 · 16 (6) · 698
DOI: 10.3390/pharmaceutics16060698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 23.05.2024. Verfasst von Maria Júlia Mancim-Imbriani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnosis and Surgery, São Paulo State University (UNESP), School of Dentistry, Araraquara CEP 14801-385, São Paulo, Brazil. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, São Paulo Research Foundation (FAPESP).
Abstract (Originalsprache)
Alternative therapies associating natural products and nanobiotechnology show new perspectives on controlled drug release. In this context, nanoemulsions (NEs) present promising results for their structural design and properties. Hesperetin (HT), a flavonoid mainly found in citrus fruits, presents highlighted bone benefits. In this context, we developed a hesperetin-loaded nanoemulsion (HT-NE) by sonication method and characterized it by dynamic light scattering, analyzing its encapsulation efficiency, and cumulative release. The biocompatibility in human osteoblasts Saos-2-like was evaluated by the cytotoxicity assay and IC50. Then, the effects of the HT-NE on osteogenesis were evaluated by the cellular proliferation, calcium nodule formation, bone regulators gene expression, collagen quantification, and alkaline phosphatase activity. The results showed that the formulation presented ideal values of droplet size, polydispersity index, and zeta potential, and the encapsulation efficiency was 74.07 ± 5.33%, showing a gradual and controlled release. Finally, HT-NE was shown to be biocompatible and increased cellular proliferation, and calcium nodule formation, regulated the expression of Runx2, ALPL, and TGF-β genes, and increased the collagen formation and alkaline phosphatase activity. Therefore, the formulation of this NE encapsulated the HT appropriately, allowing the increasing of its effects on mechanisms to improve or accelerate the osteogenesis process.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnosis and Surgery, São Paulo State University (UNESP), School of Dentistry, Araraquara CEP 14801-385, São Paulo, Brazil.
- Department of Physiology and Pathology, São Paulo State University (UNESP), School of Dentistry, Araraquara CEP 14801-385, São Paulo, Brazil.
- Department of Drugs and Medicines, São Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara CEP 14800-903, São Paulo, Brazil.
ORCID-Profile: Maria Júlia Mancim-Imbriani, Jonatas Lobato Duarte, Leonardo Delello Di Filippo, Marlus Chorilli, Patricia Milagros Maquera-Huacho
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- São Paulo Research Foundation (FAPESP)
Zitieren
APA
Mancim-Imbriani, M. J., Duarte, J. L., Di Filippo, L. D., Durão, L. P. L., Chorilli, M., Palomari Spolidorio, D. M., & Maquera-Huacho, P. M. (2024). Formulation of a Novel Hesperetin-Loaded Nanoemulsion and Its Promising Effect on Osteogenesis. Pharmaceutics, 16(6), 698. https://doi.org/10.3390/pharmaceutics16060698
Vancouver
Mancim-Imbriani MJ, Duarte JL, Di Filippo LD, Durão LPL, Chorilli M, Palomari Spolidorio DM, et al. Formulation of a Novel Hesperetin-Loaded Nanoemulsion and Its Promising Effect on Osteogenesis. Pharmaceutics. 2024;16(6):698. doi:10.3390/pharmaceutics16060698
BibTeX
@article{MancimImbriani2024,
author = {Mancim-Imbriani, Maria Júlia and Duarte, Jonatas Lobato and Di Filippo, Leonardo Delello and Durão, Letícia Pereira Lima and Chorilli, Marlus and Palomari Spolidorio, Denise Madalena and Maquera-Huacho, Patricia Milagros},
title = {Formulation of a Novel Hesperetin-Loaded Nanoemulsion and Its Promising Effect on Osteogenesis},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {6},
pages = {698},
doi = {10.3390/pharmaceutics16060698}
}
EUVIMED